Search research articles
Contact Us
Filters
Showing results (51-60 of 254) with videos related to
Page
of 26
Sort By:
Current Opinion in Psychiatry
|
June 30, 2012
Osteoporosis and fracture risk in people with schizophrenia
Taishiro Kishimoto, Marc De Hert, Harold E Carlson, et al.
Psychiatria Danubina
|
November 8, 2012
Acute effects of progressive muscle relaxation on state anxiety and subjective well-being in chronic Bulgarian patients with schizophrenia
Asen Georgiev, Michel Probst, Marc De Hert, et al.
Schizophrenia Research
|
March 22, 2006
Stereotypy in schizophrenia
Manuel Morrens, Wouter Hulstijn, Paul J Lewi, et al.
Therapeutic Advances in Psychopharmacology
|
October 30, 2013
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
Kyoko Higashi, Goran Medic, Kavi J Littlewood, et al.
Journal of Mental Health (Abingdon, England)
|
January 14, 2014
Understanding the role of physiotherapists in schizophrenia: an international perspective from members of the International Organisation of Physical Therapists in Mental Health (IOPTMH)
Brendon Stubbs, Andy Soundy, Michel Probst, et al.
International Journal of Psychiatry in Clinical Practice
|
June 20, 2014
Validation study of PECC (Psychosis Evaluation tool for Common use by Caregivers): Interscale validity and inter-rater reliability
Marc De Hert, Martien Wampers, Erik Thys, et al.
Current Pharmaceutical Design
|
June 22, 2012
Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions
Jeroen Decoster, Jim van Os, Inez Myin-Germeys, et al.
Community Mental Health Journal
|
June 22, 2011
Quality assessment of physical activity recommendations within clinical practice guidelines for the prevention and treatment of cardio-metabolic risk factors in people with schizophrenia
Davy Vancampfort, Kim Sweers, Michel Probst, et al.
Expert Opinion on Drug Safety
|
May 9, 2012
Safety and tolerability of antipsychotic polypharmacy
Juan A Gallego, Jimmi Nielsen, Marc De Hert, et al.
Psychiatry and Clinical Neurosciences
|
August 15, 2013
Diabetes, physical activity participation and exercise capacity in patients with schizophrenia
Davy Vancampfort, Marc De Hert, Kim Sweers, et al.
Page
of 26
Search research articles
Search
Showing results (51-60 of 254) with videos related to
Sort By:
Page
of 26
Current Opinion in Psychiatry
|
June 30, 2012
Osteoporosis and fracture risk in people with schizophrenia
Taishiro Kishimoto, Marc De Hert, Harold E Carlson, et al.
Psychiatria Danubina
|
November 8, 2012
Acute effects of progressive muscle relaxation on state anxiety and subjective well-being in chronic Bulgarian patients with schizophrenia
Asen Georgiev, Michel Probst, Marc De Hert, et al.
Schizophrenia Research
|
March 22, 2006
Stereotypy in schizophrenia
Manuel Morrens, Wouter Hulstijn, Paul J Lewi, et al.
Therapeutic Advances in Psychopharmacology
|
October 30, 2013
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
Kyoko Higashi, Goran Medic, Kavi J Littlewood, et al.
Journal of Mental Health (Abingdon, England)
|
January 14, 2014
Understanding the role of physiotherapists in schizophrenia: an international perspective from members of the International Organisation of Physical Therapists in Mental Health (IOPTMH)
Brendon Stubbs, Andy Soundy, Michel Probst, et al.
International Journal of Psychiatry in Clinical Practice
|
June 20, 2014
Validation study of PECC (Psychosis Evaluation tool for Common use by Caregivers): Interscale validity and inter-rater reliability
Marc De Hert, Martien Wampers, Erik Thys, et al.
Current Pharmaceutical Design
|
June 22, 2012
Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions
Jeroen Decoster, Jim van Os, Inez Myin-Germeys, et al.
Community Mental Health Journal
|
June 22, 2011
Quality assessment of physical activity recommendations within clinical practice guidelines for the prevention and treatment of cardio-metabolic risk factors in people with schizophrenia
Davy Vancampfort, Kim Sweers, Michel Probst, et al.
Expert Opinion on Drug Safety
|
May 9, 2012
Safety and tolerability of antipsychotic polypharmacy
Juan A Gallego, Jimmi Nielsen, Marc De Hert, et al.
Psychiatry and Clinical Neurosciences
|
August 15, 2013
Diabetes, physical activity participation and exercise capacity in patients with schizophrenia
Davy Vancampfort, Marc De Hert, Kim Sweers, et al.
Page
of 26